在神经外科患者的中枢神经系统术后感染中,单疗法与组合疗法的比较有效性:一项回顾性队列研究
Muyun Li1,2, Wei Meng1,3, Linna An1,4,5
1State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China.
BMC infectious diseases
|May 2, 2025
概括
在神经外科病人的复杂中枢神经系统感染 (CNSIs) 中,万科米辛组合疗法 (VCT) 显示出优于单药疗法 (SDT) 的疗效. 虽然SDT在某些情况下是有效的,但VCT在复杂的感染中更好地获得更好的结果.
科学领域:
- 神经外科 神经外科
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 临床指导方针主张基于万科米辛的组合疗法用于术后神经外科感染.
- 全球抗生素耐药性和抗菌药物管理导致单药疗法 (SDT) 的使用增加.
研究的目的:
- 为了比较单药疗法 (SDT) 与中枢神经系统感染 (CNSIs) 后神经外科手术的万科米辛组合疗法 (VCT) 的疗效.
主要方法:
- 以后视的队列研究,使用 1:2 比例的倾向性得分匹配 (PSM).
- 调整为共变量,包括停留时间,入院状态,年龄,并发症 (CCI),手术因素和手术持续时间 (DOS).
- 使用PSM和用于强度的后勤回归评估治疗效应.
主要成果:
- 在PSM之后,177名患者接受SDT,101名患者接受VCT.
- 与SDT (76%) (p=0.007) 相比,VCT显示了更高的临床治愈率 (90%).
- 在未调整的 (OR 2.941) 和调整的 (OR 3.605) 模型中,VCT的效果明显高于SDT,特别是在复杂感染中.
结论:
- 范科米辛组合疗法 (VCT) 是神经外科中复杂的中枢神经系统感染 (CNSIs) 的首选治疗方法.
- 单药疗法 (SDT) 在某些情况下仍然有效,但仔细考虑感染复杂性和抗生素耐药性至关重要.
- 研究结果为优化手术后中枢神经神经系统疾病的治疗策略提供了宝贵的见解.
相关概念视频
01:29Drug Delivery: Parenteral Route
313
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
313
01:27Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K